Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects

NCT00352911 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: VGX-410 (Mifepristone)
DRUG: Placebo for VGX-410 (Mifepristone)

Sponsor

VGX Pharmaceuticals, LLC